Lusacomfar alfa
芦沙补体因子α
Report date: 2023/03/17 14:21:52
Base Information
Drug NameLusacomfar alfa
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[4]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGemini Therapeutics Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesGemini Therapeutics Inc
Active IndicationsN/A
Inactive Indications +[4]
Other Information
ATC CodeN/A
Related LinksN/A